243 related articles for article (PubMed ID: 25480462)
1. Comparison of the effects of escitalopram and nortriptyline on painful symptoms in patients with major depression.
Jaracz J; Gattner K; Moczko J; Hauser J
Gen Hosp Psychiatry; 2015; 37(1):36-9. PubMed ID: 25480462
[TBL] [Abstract][Full Text] [Related]
2. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
Strohmaier J; Wüst S; Uher R; Henigsberg N; Mors O; Hauser J; Souery D; Zobel A; Dernovsek MZ; Streit F; Schmäl C; Kozel D; Placentino A; Farmer A; McGuffin P; Aitchison KJ; Rietschel M
World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237
[TBL] [Abstract][Full Text] [Related]
3. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.
Uher R; Maier W; Hauser J; Marusic A; Schmael C; Mors O; Henigsberg N; Souery D; Placentino A; Rietschel M; Zobel A; Dmitrzak-Weglarz M; Petrovic A; Jorgensen L; Kalember P; Giovannini C; Barreto M; Elkin A; Landau S; Farmer A; Aitchison KJ; McGuffin P
Br J Psychiatry; 2009 Mar; 194(3):252-9. PubMed ID: 19252156
[TBL] [Abstract][Full Text] [Related]
4. [Association between polymorphisms of ins/del in the 5-HTT gene and T102C in the 5HTR2A gene and the drug response for escitalopram and nortriptyline in depressed patients].
Rajewska-Rager A; Dmitrzak-Weglarz M; Kapelski P; Skibińska M; Kaczmarkiewicz-Fass M; Hauser J
Psychiatr Pol; 2008; 42(6):903-14. PubMed ID: 19441667
[TBL] [Abstract][Full Text] [Related]
5. Genetic disposition to inflammation and response to antidepressants in major depressive disorder.
Zwicker A; Fabbri C; Rietschel M; Hauser J; Mors O; Maier W; Zobel A; Farmer A; Aitchison KJ; McGuffin P; Lewis CM; Uher R
J Psychiatr Res; 2018 Oct; 105():17-22. PubMed ID: 30130674
[TBL] [Abstract][Full Text] [Related]
6. [Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression].
Rajewska-Rager A; Skibińska M; Szczepankiewicz A; Kapelski P; Dmitrzak-Weglarz M; Leszczyńska-Rodziewicz A; Hauser J
Psychiatr Pol; 2008; 42(6):915-23. PubMed ID: 19441668
[TBL] [Abstract][Full Text] [Related]
7. Is Venlafaxine More Effective than Escitalopram and Nortriptyline in the Management of Painful Symptoms in Patients with Major Depression?
Jaracz J; Gattner K; Jaracz K; Górna K; Moczko J; Hauser J
Pharmacopsychiatry; 2018 Jul; 51(4):148-152. PubMed ID: 29141255
[TBL] [Abstract][Full Text] [Related]
8. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
9. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
Köhler-Forsberg O; Larsen ER; Buttenschøn HN; Rietschel M; Hauser J; Souery D; Maier W; Farmer A; McGuffin P; Aitchison KJ; Uher R; Mors O
Br J Psychiatry; 2019 Aug; 215(2):494-501. PubMed ID: 30698114
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment factor structures of the Montgomery and Åsberg Depression Rating scale as predictors of response to escitalopram in Indian patients with non-psychotic major depressive disorder.
Basu A; Chadda R; Sood M; Rizwan SA
Asian J Psychiatr; 2017 Aug; 28():154-159. PubMed ID: 28784374
[TBL] [Abstract][Full Text] [Related]
11. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
Mohamed S; Osatuke K; Aslam M; Kasckow J
Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.
Aragona M; Bancheri L; Perinelli D; Tarsitani L; Pizzimenti A; Conte A; Inghilleri M
Eur J Pain; 2005 Feb; 9(1):33-8. PubMed ID: 15629872
[TBL] [Abstract][Full Text] [Related]
13. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study.
Hoare J; Carey P; Joska JA; Carrara H; Sorsdahl K; Stein DJ
J Nerv Ment Dis; 2014 Feb; 202(2):133-7. PubMed ID: 24469525
[TBL] [Abstract][Full Text] [Related]
15. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
[TBL] [Abstract][Full Text] [Related]
17. Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of change.
Farabaugh A; Fisher L; Nyer M; Holt D; Cohen M; Baer L; Shapero BG; Huz I; Cardoos A; Fava M; Alpert JE
Ann Clin Psychiatry; 2015 May; 27(2):118-26. PubMed ID: 25954938
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.
Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS
J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
